IL-7R expression and IL-7 signaling confer a distinct phenotype on developing human B-lineage cells

Blood

Volumn 118, Issue 8, 2011, Pages 2116-2127

  Nodland, Sonja E ^a   Berkowska, Magdalena A ^b   Bajer, Anna A ^a   Shah, Nisha ^a   De Ridder, Dick ^c   Van Dongen, Jacques J M ^b   LeBien, Tucker W ^a   Van Zelm, Menno C ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Delft University of Technology ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN LIGHT CHAIN; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR;

ARTICLE; CD19+ CD127+ CELL; CD19+ CD127- CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL POPULATION; CELL STRUCTURE; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE INSERTION; GENE LOCUS; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LYMPHOCYTE; MICROARRAY ANALYSIS; PHENOTYPE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERODIAGNOSIS; SIGNAL TRANSDUCTION; XENOGRAFT;

EID: 80052153064     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-08-302513     Document Type: Article

References (50)

1. Hardy RR, Kincade PW, Dorshkind K. The protean nature of cells in the B lymphocyte lineage. Immunity. 2007;26(6):703-714.
2. LeBien TW, Tedder TF. 2008. B lymphocytes: how they develop and function. Blood. 2008;112(5):1570-1580.
3. Chowdhury D, Sen R. Regulation of immunoglobulin heavy chain rearrangements. Immunol Rev. 2004;200:182-196.
4. Jung D, Giallourakis C, Mostoslavsky R, Alt FW. Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu Rev Immunol. 2006;24:541-570.
5. Fugmann FD, Lee AI, Shockett PE, Villey IJ, Schatz DG. The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Annu Rev Immunol. 2000;18:495-527.
6. Gellert M. V(D)J recombination: RAG proteins, repair factors and regulation. Annu Rev Biochem. 2002;71:101-132.
7. Herzog S, Reth M, Jumaa H. Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signaling. Nat Rev Immunol. 2009;9(3):195-205.
8. Nutt SL, Kee BL. The transcriptional regulation of B cell lineage commitment. Immunity. 2007;26(6):715-725.
9. Corcoran AE, Riddell A, Krooshoop D, Venkitaraman AR. Impaired immunoglobulin gene rearrangement in mice lacking the IL-7 receptor. Nature. 1998;391(6670):904-907.
10. Bertolino E, Reddy K, Medina KL, Parganas E, Ihle J, Singh H. Regulation of interleukin 7-dependent immunoglobulin heavy-chain variable gene rearrangements by transcription factor STAT5. Nat Immunol. 2005;6(8):836-843.
11. Kikuchi K, Lai AY, Hsu C-L, Kondo M. IL-7 receptor signaling is necessary for stage transition in adult B cell development through up-regulation of EBF. J Exp Med. 2005;201(8):1197-1203.
12. Stanton ML, Brodeur PH. 2005. Cutting Edge: Stat5 mediates the IL-7-induced accessibility of a representative D-distal VH gene. J Immunol. 2005;174(6):3164-3168.
13. Malin S, McManus S, Cobaleda C, et al. Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development. Nat Immunol. 2010;11(2):171-179.
14. LeBien TW. Fates of human B-cell precursors. Blood. 2000;96(1):9-23.
15. Buckley RH. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol. 2004;22:625-655.
16. Giliani S, Mori L, Basile GS, et al. Interleukin-7 receptor (IL-7Ralpha) deficiency; cellular and molecular bases: analysis of clinical, immunological, and molecular features in 16 novel patients. Immunol Rev. 2005;203:110-126.
17. Johnson SE, Shah N, Panoskaltsis-Mortari A, LeBien TW. Murine and human IL-7 activate STAT5 and induce proliferation of normal human pro-B cells. J Immunol. 2005;175(11):7325-7331.
18. Johnson SE, Shah N, Bajer AA, LeBien TW. IL-7 activates the phosphatidylinositol 3-kinase/AKT pathway in normal human thymocytes but not normal human B cell precursors. J Immunol. 2008;180(12):8109-8117.
19. Berardi AC, Meffre EF, Pflumio F, et al. Individual CD34+CD38lowCD19- CD10- progenitor cells from human cord blood generate B-lymphocytes and granulocytes. Blood. 1997;89(10):3554-3564.
20. Nishihara M, Wada Y, Ogami K, et al. A combination of stem cell factor and granulocyte colony-stimulating factor enhances the growth of human progenitor B cells supported by murine stromal cell line MS-5. Eur J Immunol. 1998;28(3):855-864.
21. Ohkawara JI, Ikebuchi K, Fujihara M, et al. Culture system for extensive production of CD19+IgM+ cells by human cord blood CD34+ progenitors. Leukemia. 1998;12(5):764-771.
22. Rossi MI, Yokota T, Medina KL, et al. B lymphopoiesis is active throughout human life, but there are developmental age-related changes. Blood. 2003;101(2):576-584.
23. van Zelm MC, van der Burg M, de Ridder D, et al. Ig gene rearrangement steps are initiated in early human B cell precursor subsets and correlate with specific transcription factor expression. J Immunol. 2005;175(9):5912-5922.
24. Dittel BN, LeBien TW. The growth response to IL-7 during normal human B cell ontogeny is restricted to B-lineage cells expressing CD34. J Immunol. 1995;154(1):58-67.
25. Hystad ME, Myklebust JH, Bo TH, et al. Characterization of early stages of human B cell development by gene expression profiling. J Immunol. 2007;179(6):3662-3671.
26. Parrish YK, Baez I, Milford T-A, et al. IL-7 dependence in human B lymphopoiesis increases during progression of ontogeny from cord blood to bone marrow. J Immunol. 2009;182(7):4255-4266.
27. Rao SP, Riggs JM, Friedman DF, Scully MS, LeBien TW, Silberstein LE. Biased VH usage in early lineage human B cells: evidence for preferential Ig gene rearrangement in the absence of selection. J Immunol. 1999;163(5):2732- 2740.
28. Langerak AW, Nadel B, De Torbal A, et al. Unraveling the consecutive recombination events in the human IGK locus. J Immunol. 2004;173(6):3878-3888.
29. van der Burg M, Tumkaya T, Boerma M, de Bruin-Versteeg S, Langerak AW, van Dongen JJ. Ordered recombination of immunoglobulin light chain genes occurs at the IGK locus but seems less strict at the IGL locus. Blood. 2001;97(4):1001-1008.
30. Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE. Identification and characterization of circulating human transitional B cells. Blood. 2005;105(11):4390-4398.
31. Sayegh T, Jhunjhunwala S, Riblet R, Murre C. Visualization of looping involving the immunoglobulin heavy-chain locus in developing B cells. Genes Dev. 2005;19(3):322-327.
32. Jhunjhunwala S, van Zelm MC, Peak MM, et al. 3D-Architecture of the immunoglobulin heavy chain locus: implications for long-range genomic interactions. Cell. 2008;133(2):265-279.
33. Kosak ST, Skok JA, Medina KL, et al. Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development. Science. 2002;296(5565):158- 162.
34. Roldán E, Fuxa M, Chong W, et al. Locus 'decontraction' and centromeric recruitment contribute to allelic exclusion of the immunoglobulin heavychain gene. Nat Immunol. 2005;6(1):31-41.
35. Poulsen TS, Silahtaroglu AN, Gisselø CG, et al. Detection of illegitimate rearrangement within the immunoglobulin locus on 14q32.3 in B-cell malignancies using end-sequenced probes. Genes Chromosomes Cancer. 2001;32(3):265-274
36. Duy C, Yu JJ, Nahar R, et al. Bcl-6 is critical for the development of a diverse primary B cell repertoire. J Exp Med. 2010;207(6):1209-1221.
37. Prieyl JA, LeBien TW. Interleukin 7 independent development of human B cells. Proc Natl Acad Sci U S A. 1996;93(19):10348-10353.
38. Urbánek P, Wang ZQ, Fetka I, Wagner EF, Busslinger M. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell. 1994;79(5):901-912.
39. Fuxa M, Slok J, Souabni A, Salvagiotto G, Roldan E, Busslinger M. Pax5 induces V-to-DJ rearrangements and locus contraction of the immunoglobulin heavy-chain gene. Genes Dev. 2004;18(4):411-422.
40. Zhang Z, Espinoza CR, Yu Z et al. Transcription factor Pax5 (BSAP) transactivates the RAG-mediated VH-to-DJH rearrangement of immunoglobulin genes. Nat Immunol. 2006;7(6):616-624.
41. Kubagawa H, Cooper MD, Carroll AJ, Burrows PD. Light chain gene expression before heavy chain gene rearrangement in pre-B cells transformed by Epstein-Barr virus. Proc Natl Acad Sci U S A. 1989;86(7):2356-2360.
42. Novobrantseva TI, Martin VM, Pelanda R, Muller W, Rajewsky K, Ehlich A. Rearrangement and expression of immunoglobulin light chain genes can precede heavy chain expression during normal B cell development in mice. J Exp Med. 1999;189(1):75-88.
43. Meffre E, Milili M, Blanco-Betancourt C, Antunes H, Nussenzweig MC, Schiff C. Immunoglobulin heavy chain expression shapes the B cell repertoire in human B cell development. J Clin Invest. 2001;108(6):879-886.
44. Milne CD, Paige CJ. IL-7: a key regulator of B lymphopoiesis. Semin Immunol. 2006;18(1):20-30.
45. Mazzucchelli R, Durum SK. Interleukin-7 receptor expression: intelligent design. Nat Rev Immunol. 2007;7(2):144-154.
46. Romanow WJ, Langerak AW, Goebel P, et al. E2A and EBF act in synergy with the V (D) J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol Cell. 2000;5(2):343-353.
47. Dengler HS, Barocho GV, Omori SA, et al. Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation. Nat Immunol. 2008;9(12):1388-1398.
48. Amin RH, Schlissel MS. Foxo1 directly regulates the transcription of recombination activating genes during B cell development. Nat Immunol. 2008;9(6):613-622.
49. Chowdhury D, Sen R. Stepwise activation of the immunoglobulin mu heavy chain gene locus. EMBO J. 2001;20(22):6394-6403.
50. Sportès C, Babb RR, Krumlauf MC, et al. Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy. Clin Cancer Res. 2010;16(2):727-735.